The approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna’s existing vaccine. The US approved a new COVID-19 vaccine made by Moderna ...

While she doesn't support use of compounded GLP-1s, Dushay predicted that the new restrictions may strain the supply of approved drugs, especially at initial dosages. The FDA said that drugmakers ...

Additional findings are displayed in net league tables, forest plots, and funnel plot. Conclusions: A daily dose of 100 ml of XBJ was associated with improvement in APTT and CRP levels in patients ...